- Home
- SCLXW vs FISK Comparison
SCLXW vs FISK Comparison
Compare SCLXW & FISK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- FISK
- Stock Information
- Founded
- SCLXW N/A
- FISK N/A
- Country
- SCLXW United States
- FISK
- Employees
- SCLXW 111
- FISK 667
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- FISK
- Sector
- SCLXW Health Care
- FISK
- Exchange
- SCLXW Nasdaq
- FISK NYSE
- Market Cap
- SCLXW N/A
- FISK N/A
- IPO Year
- SCLXW N/A
- FISK N/A
- Fundamental
- Price
- SCLXW $0.10
- FISK $8.30
- Analyst Decision
- SCLXW
- FISK
- Analyst Count
- SCLXW 0
- FISK 0
- Target Price
- SCLXW N/A
- FISK N/A
- AVG Volume (30 Days)
- SCLXW 4.0K
- FISK N/A
- Earning Date
- SCLXW 03-07-2025
- FISK N/A
- Dividend Yield
- SCLXW N/A
- FISK N/A
- EPS Growth
- SCLXW N/A
- FISK N/A
- EPS
- SCLXW N/A
- FISK N/A
- Revenue
- SCLXW $55,152,000.00
- FISK N/A
- Revenue This Year
- SCLXW N/A
- FISK N/A
- Revenue Next Year
- SCLXW N/A
- FISK N/A
- P/E Ratio
- SCLXW N/A
- FISK N/A
- Revenue Growth
- SCLXW 22.02
- FISK N/A
- 52 Week Low
- SCLXW $0.18
- FISK N/A
- 52 Week High
- SCLXW $0.18
- FISK N/A
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- FISK 83.17
- Support Level
- SCLXW N/A
- FISK $6.77
- Resistance Level
- SCLXW N/A
- FISK $8.47
- Average True Range (ATR)
- SCLXW 0.00
- FISK 0.06
- MACD
- SCLXW 0.00
- FISK 0.04
- Stochastic Oscillator
- SCLXW 0.00
- FISK 59.89
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About FISK EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.